Skip to Main Content

09.10.03 - Racing Commission - Proposed Regulations

PROPOSED ACTION ON REGULATIONS
MARYLAND REGISTER, VOLUME 44, ISSUE 23,
FRIDAY, NOVEMBER 13, 2017

Title 09 DEPARTMENT OF LABOR, LICENSING, AND REGULATION

Subtitle 10 RACING COMMISSION

09.10.03 Prohibited Acts

Authority: Business Regulation Article, §11-210, Annotated Code of Maryland

Notice of Proposed Action
[17272-P]

The Maryland Racing Commission proposes to amend Regulation .01-1 under COMAR 09.10.03 Prohibited Acts. This action was considered at a public meeting held on September 28, 2017, notice of which appeared in the Maryland Register on September 1, 2017.

Statement of Purpose

The purpose of this action is to update the current regulation regarding the permissive threshold of detomidine that is allowed to be in a horse’s system during a race.

Comparison to Federal Standards

There is no corresponding federal standard to this proposed action.

Estimate of Economic Impact

The proposed action has no economic impact.

Economic Impact on Small Businesses

The proposed action has minimal or no economic impact on small businesses.

Impact on Individuals with Disabilities

The proposed action has no impact on individuals with disabilities.

Opportunity for Public Comment

Comments may be sent to J. Michael Hopkins, Executive Director, Maryland Racing Commission, 300 East Towsontown Boulevard, Towson, MD 21286, or call 410-296-9682, or email to mike.hopkins@maryland.gov, or fax to 410-296-9687. Comments will be accepted through January 22, 2018. A public hearing has not been scheduled.

.01-1 Restricted Use of Medications and Other Substances.
The use of the following medications and other substances are permitted if quantitated at not more than the specified thresholds:
  A. — F. (text unchanged)
  G. Detomidine quantitated at not more than [1 nanogram] 2 nanograms per milliliter of carboxydetomidine in urine, or [the limit of detection for detomidine in] 1 nanogram of detomidine per milliliter of blood plasma or serum;
  H. — CC. (text unchanged)

J. MICHAEL HOPKINS
Executive Director